Wim M Mulleners
Overview
Explore the profile of Wim M Mulleners including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
496
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brandt R, Wilbrink L, de Coo I, Haan J, Mulleners W, Huygen F, et al.
EBioMedicine
. 2023 Nov;
98:104895.
PMID: 38007947
Background: We demonstrated in the randomised controlled ICON study that 48-week treatment of medically intractable chronic cluster headache (MICCH) with occipital nerve stimulation (ONS) is safe and effective. In L-ICON...
2.
Kooijman N, Willegers T, Reuser A, Mulleners W, Kramers C, Vissers K, et al.
Pain Pract
. 2023 Jan;
23(4):447-458.
PMID: 36597700
Aims: We aim to provide an evidence-based overview of the use of psychedelics in chronic pain, specifically LSD and psilocybin. Content: Chronic pain is a common and complex problem, with...
3.
Henssen D, Kluin S, Kleerebezem J, van Walsum A, Mulleners W, Vissers K
Pain
. 2021 Jul;
163(4):779-785.
PMID: 34321411
Chronic migraine (CM) is a disabling neurologic disorder that affects approximately 2% of the general population. Neuroimaging studies show functional involvement of trigeminal structures, such as the trigeminal spinal nucleus...
4.
Wilbrink L, de Coo I, Doesborg P, Mulleners W, Teernstra O, Bartels E, et al.
Lancet Neurol
. 2021 Jun;
20(7):515-525.
PMID: 34146510
Background: Occipital nerve stimulation (ONS) has shown promising results in small uncontrolled trials in patients with medically intractable chronic cluster headache (MICCH). We aimed to establish whether ONS could serve...
5.
Mulleners W, Kim B, Lainez M, Lanteri-Minet M, Pozo-Rosich P, Wang S, et al.
Lancet Neurol
. 2020 Sep;
19(10):814-825.
PMID: 32949542
Background: Many patients who require migraine preventive treatment have not been able to tolerate or have not responded to multiple previous preventive medications. We aimed to assess the safety and...
6.
Toro R, Downward G, van der Mark M, Brouwer M, Huss A, Peters S, et al.
Environ Int
. 2019 May;
129:28-34.
PMID: 31103844
Background: There is some evidence to suggest an association between ambient air pollution and development of Parkinson's disease (PD). However, the small number of studies published to date has reported...
7.
van der Meer H, Visscher C, Engelbert R, Mulleners W, Nijhuis-van Der Sanden M, Speksnijder C
Musculoskelet Sci Pract
. 2017 Jul;
31:52-61.
PMID: 28734169
Background: Headache is a common disorder which may lead to substantial socio-economic loss. Treatment options include self-management strategies, medication and physiotherapy. Physiotherapists need to be able to screen for the...
8.
Brouwer M, Huss A, van der Mark M, Nijssen P, Mulleners W, Sas A, et al.
Environ Int
. 2017 Jul;
107:100-110.
PMID: 28704700
Background: Exposure to pesticides has been linked to Parkinson's disease (PD), although associations between specific pesticides and PD have not been well studied. Residents of rural areas can be exposed...
9.
Chronicle E, Mulleners W
Cochrane Database Syst Rev
. 2016 May;
(5):CD003226.
PMID: 27233055
No abstract available.
10.
van der Mark M, Vermeulen R, Nijssen P, Mulleners W, Sas A, van Laar T, et al.
Parkinsonism Relat Disord
. 2015 Apr;
21(6):635-9.
PMID: 25903042
Objectives: The aim of this study was to investigate the potential association between occupational exposure to solvents, metals and/or welding fumes and risk of developing Parkinson's disease (PD). Methods: Data...